Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study
Medicines · 27.02.2023 · 10 (3) · 19
DOI: 10.3390/medicines10030019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicines, online erschienen am 27.02.2023. Verfasst von Athanasios Garavelas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Life, IASO Maternity Hospital, 37-39, Kifissias Avenue, 151 23 Athens, Greece. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The intraovarian administration of autologous platelet-rich plasma (PRP) acts beneficially for the stimulation of follicle production in women presenting different forms of ovarian dysfunction. This pilot study aimed to evaluate and provide significant data regarding the efficacy of PRP to rejuvenate the ovaries.
Methods
A total of 253 women aged 22–56 years, were divided into five groups, based on their status. All participants signed for informed consent for the current study. Blood sampling, preparation of PRP and intraovarian infusion of the latter were performed on all participants. The evaluation of PRP efficacy, a two-month follow-up detecting the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and anti-mullerian hormone (AMH), was performed for all participants. For women with advanced ages (>48 years), the restoration and regularity of the menstrual cycle were additionally evaluated.
Results
After the two-month follow-up, the majority of the participants presented improvement in their hormonal profiles. Additionally, 17% of the women in this pilot study successfully conceived. The restoration of the menstrual cycle was detected in 15% of the women with advanced ages.
Conclusions
Intraovarian infusion of autologous PRP exhibited remarkable evidence and promising results to restore ovarian insufficiency.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Life, IASO Maternity Hospital, 37-39, Kifissias Avenue, 151 23 Athens, Greece.
- Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Efessiou Street, 115 27 Athens, Greece.
ORCID-Profile: Athanasios Garavelas, Panagiotis Mallis, Efstathios Michalopoulos
Zitieren
APA
Garavelas, A., Mallis, P., Michalopoulos, E., & Nikitos, E. (2023). Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study. Medicines, 10(3), 19. https://doi.org/10.3390/medicines10030019
Vancouver
Garavelas A, Mallis P, Michalopoulos E, Nikitos E. Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study. Medicines. 2023;10(3):19. doi:10.3390/medicines10030019
BibTeX
@article{Garavelas2023,
author = {Garavelas, Athanasios and Mallis, Panagiotis and Michalopoulos, Efstathios and Nikitos, Eros},
title = {Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study},
journal = {Medicines},
year = {2023},
volume = {10},
number = {3},
pages = {19},
doi = {10.3390/medicines10030019}
}
EUVIMED